中国组织工程研究Issue(35)：5593-5597,5.DOI:10.3969/j.issn.2095-4344.2015.35.004
唑来膦酸对髋关节置换后假体柄周围骨丢失的预防效果
Preventive effect of zoledronic acid on bone loss around the prosthesis stem after hip replacement
刘国青 1苑振峰 2刘鹏 1庞同涛 1张先巍1
作者信息
- 1. 莘县人民医院骨外科，山东省莘县 252400
- 2. 泰山医学院聊城临床学院关节外科，山 东省聊城市 252000
- 折叠
摘要
Abstract
BACKGROUND:Bone loss to different degrees may appear within 1 year after hip replacement in the femoral or acetabular sides, and severely affect long-term stability of the prosthesis and bone strength. Thus, to reduce bone loss around the prosthesis stem after total hip replacement is significant to prolong the use time of the prosthesis and to prevent fractures surrounding the prosthesis. <br> OBJECTIVE:To observe the preventive effect of zoledronic acid on bone loss surrounding the prosthesis stem after hip replacement. <br> METHODS:A total of 80 patients after total hip replacement in the People’s Hospital of Shenxian from February 2011 to September 2014 were enrol ed in this study. They were divided into two groups (n=40). At 4 days after replacement, patients in the observation group received treatment with zoledronic acid, but those in the control group did not give zoledronic acid. The rest medication was identical between the two groups. Bone mineral density in the hip was measured before replacement and at 1 year after replacement in both groups. Serum calcium and <br> phosphorus levels and alkaline phosphatase activities were observed before replacement, 3 days and 1 year after medication in the two groups. Adverse reaction during medication was recorded in the observation group. <br> RESULTS AND CONCLUSION:The average bone mineral density was significantly decreased in both groups at 1 year after replacement, and significant differences were found as compared with before replacement (P<0.05). The average bone mineral density was significantly higher in the observation group than in the control group at 1 year after <br> replacement (P<0.05). Calcium and phosphorus levels were significantly diminished at 3 days after medication as compared with that before replacement (P<0.05). Calcium and phosphorus levels maintained at the level before replacement at 1 year after medication. Alkaline phosphatase activities were slightly reduced within a short time after replacement in both groups, but no significant difference was found as compared with before replacement (P>0.05). Alkaline phosphatase activities were low in the observation group at 1 year after medication, and significant difference was detected as compared with the control group and that before replacement (P<0.05). No significant difference in alkaline phosphatase activities was detectable in the control group between 1-year post medication and pre-replacement (P>0.05). Within two or three days after medication, nine patients suffered from varying degrees of muscle aches and fever in the observation group, and above symptoms were lessened after taking acetaminophen. These results verify that after total hip replacement, zoledronic acid injection can effectively prevent bone loss around the prosthesis in early stage after replacement, but fever symptoms may occur within a week after replacement. Thus, it is recommended that zoledronic acid injection can be given at 1 week after replacement. If fever and other symptoms appear, acetaminophen can be given.关键词
植入物/人工假体/关节植入物/唑来膦酸/全髋关节置换/骨丢失/假体柄/骨密度Key words
Arthroplasty, Replacement, Hip/Bone Density/Alkaline Phosphatase分类
医药卫生引用本文复制引用
刘国青,苑振峰,刘鹏,庞同涛,张先巍..唑来膦酸对髋关节置换后假体柄周围骨丢失的预防效果[J].中国组织工程研究,2015,(35):5593-5597,5.
